Assessment of Therapy Response by Fluorine-18 Fluorodeoxyglucose PET in Infection and Inflammation

PET Clinics

Volumn 1, Issue 2, 2006, Pages 191-198

  Kumar, Rakesh ^a   Chauhan, Anil ^a   Zhuang, Hongming ^b   Alavi, Abass ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 64649105816     PISSN: 15568598     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpet.2006.03.002     Document Type: Review

References (49)

1. Kumar R., Nadig M.R., and Chauhan A. Positron emission tomography: clinical applications in oncology. Part 1. Expert Rev Anticancer Ther 5 (2005) 1079-1094
2. Kostakoglu L., Agress Jr. H., and Goldsmith S.J. Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23 (2003) 315-340
3. Kumar R., Bhargava P., Bozkurt M.F., et al. Positron emission tomography imaging in evaluation of cancer patients. Indian J Cancer 40 (2003) 87-100
4. Avril N., Sassen S., Schmalfeldt B., et al. Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J Clin Oncol 23 (2005) 7445-7453
5. Kumar R., Xiu Y., Potenta S., et al. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. J Nucl Med 45 (2004) 1796-1803
6. Dose Schwarz J., Bader M., Jenicke L., et al. Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET. J Nucl Med 46 (2005) 1144-1150
7. Theron J., and Tyler J.L. Takayasu's arteritis of the aortic arch: endovascular treatment and correlation with positron emission tomography. AJNR Am J Neuroradiol 8 (1987) 621-626
8. Zhuang H., Pourdehnad M., Lambright E.S., et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42 (2001) 1412-1417
9. Kumar R., Loving V.A., Chauhan A., et al. Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. J Nucl Med 46 (2005) 1819-1824
10. Hustinx R., Smith R.J., Benard F., et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med 26 (1999) 1345-1348
11. Hara M., Goodman P.C., and Leder R.A. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr 23 (1999) 16-18
12. Meller J., Grabbe E., Becker W., et al. Value of F-18FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol 13 (2003) 400-405
13. Brodmann M., Lipp R.W., Passath A., et al. The role of 2-F-18-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 43 (2004) 241-242
14. Balan K., Voutnis D., and Groves A. Discordant uptake of F-18FDG and In-111WBC in systemic vasculitis. Clin Nucl Med 28 (2003) 485-486
15. Derdelinckx I., Maes A., Bogaert J., et al. Positron emission tomography scan in the diagnosis and follow-up of aortitis of the thoracic aorta. Acta Cardiol 55 (2000) 193-195
16. Turlakow A., Yeung H.W., Pui J., et al. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med 161 (2001) 1003-1007
17. Meller J., Strutz F., Siefker U., et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 30 (2003) 730-736
18. Moreno D., Yuste J.R., Rodriguez M., et al. Positron emission tomography use in the diagnosis and follow up of Takayasu's arteritis. Ann Rheum Dis 64 (2005) 1091-1093
19. Bleeker-Rovers C.P., Bredie S.J., van der Meer J.W., et al. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 61 (2003) 323-329
20. Bleeker-Rovers C.P., Bredie S.J., van der Meer J.W., et al. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med 116 (2004) 50-53
21. de Leeuw K., Bijl M., and Jager P.L. Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol 22 Suppl (2004) S21-S26
22. Webb M., Chambers A., Al-Nahhas A., et al. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31 (2004) 627-634
23. Andrews J., Al-Nahhas A., Pennell D.J., et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis 63 (2004) 995-1000
24. Scheel A.K., Meller J., Vosshenrich R., et al. Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 63 (2004) 1507-1510
25. De Winter F., Van de Wiele C., Vogelaers D., et al. Fluorine-18 fluorodeoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 83 (2001) 651-660
26. Meller J., Koster G., Liersch T., et al. Chronic bacterial osteomyelitis: prospective comparison of F-18-FDG imaging with a dual-head coincidence camera and In-111-labelled autologous leucocyte scintigraphy. Eur J Nucl Med 29 (2002) 53-60
27. Robiller F.C., Stumpe K.D.M., Kossmann T., et al. Chronic osteomyelitis of the femur: value of PET imaging. Eur Radiol 10 (2000) 855-858
28. Kalicke T., Schmitz A., Risse J.H., et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 27 (2000) 524-528
29. Koort J.K., Makinen T.J., Knuuti J., et al. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J Nucl Med 45 (2004) 1406-1411
30. El Espera I., Blondet C., Moullart V., et al. The usefulness of 99mTc sulfur colloid bone marrow scintigraphy combined with 111In leucocyte scintigraphy in prosthetic joint infection. Nucl Med Commun 25 (2004) 171-175
31. Joseph T.N., Mujtaba M., Chen A.L., et al. Efficacy of combined technetium-99m sulfur colloid/indium-111 leukocyte scans to detect infected total hip and knee arthroplasties. J Arthroplasty 16 (2001) 753-758
32. Love C., Marwin S.E., Tomas M.B., et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med 45 (2004) 1864-1871
33. Zhuang H., Chacko T.K., Hickeson M., et al. Persistent non-specific FDG uptake on PET imaging following hip arthroplasty. Eur J Nucl Med Mol Imaging 29 (2002) 1328-1333
34. Chacko T.K., Zhuang H., Stevenson K., et al. The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses. Nucl Med Commun 23 (2002) 851-855
35. Kortelainen M.L. Adiposity, cardiac size and precursors of coronary atherosclerosis in 5 to 15-year-old children: a retrospective study of 210 violent deaths. Int J Obes Relat Metab Disord 21 (1997) 691-697
36. Daniels S.R. Cardiovascular disease risk factors and atherosclerosis in children and adolescents. Curr Atheroscler Rep 3 (2001) 479-485
37. Andrews J., Al-Nahhas A., Pennell D., et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis 63 (2004) 995-1000
38. Ben-Haim S., Kupzov E., Tamir A., et al. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 45 (2004) 1816-1821
39. El-Haddad G., Zhuang H., Gupta N., et al. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med 34 (2004) 313-329
40. 18F]-fluorodeoxyglucose positron emission tomography. Circulation 105 (2002) 2708-2711
41. Baller D., Notohamiprodjo G., Gleichmann U., et al. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 99 (1999) 2871-2875
42. Kotilainen P., Airas L., Kojo T., et al. Positron emission tomography as an aid in the diagnosis and follow-up of Riedel's thyroiditis. Eur J Intern Med 15 (2004) 186-189
43. Drieskens O., Blockmans D., Van den Bruel A., et al. Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomographic findings. Clin Nucl Med 27 (2002) 413-415
44. Tsuyuguchi N., Sunada I., Ohata K., et al. Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine. Ann Nucl Med 17 (2003) 47-51
45. Scheid R., Lincke T., Voltz R., et al. Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol 61 (2004) 1785-1789
46. Moosig F., Czech N., Mehl C., et al. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 63 (2004) 870-873
47. Bleeker-Rovers C.P., de Sevaux R.G., van Hamersvelt H.W., et al. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis 41 (2003) E18-E21
48. Wyss M.T., Honer M., Spath N., et al. Influence of ceftriaxone treatment on FDG uptake-an in vivo [18F]-fluorodeoxyglucose imaging study in soft tissue infections in rats. Nucl Med Biol 31 (2004) 875-882
49. Win Z., Todd J., and Al-Nahhas A. FDG-PET imaging in Pneumocystis carinii pneumonia. Clin Nucl Med 30 (2005) 690-691